ConductScience.org, home

Paper · 38516890

References61

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126509589AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidney disease.Kidney Int2016https://conductscience.org/library/papers/26509589PubMed
230990260Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.N Engl J Med2019https://conductscience.org/library/papers/30990260PubMed
320360309Macula densa sensing and signaling mechanisms of renin release.J Am Soc Nephrol2010https://conductscience.org/library/papers/20360309PubMed
429600408Independent regulation of renin-angiotensin-aldosterone system in the kidney.Clin Exp Nephrol2018https://conductscience.org/library/papers/29600408PubMed
512655045Macula densa cell signaling involves ATP release through a maxi anion channel.Proc Natl Acad Sci U S A2003https://conductscience.org/library/papers/12655045PubMed
637814337The complexity of nicotinamide adenine dinucleotide (NAD), hypoxic, and aryl hydrocarbon receptor cell signaling in chronic kidney disease.J Transl Med2023https://conductscience.org/library/papers/37814337PubMed
711849399Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production.Kidney Int2002https://conductscience.org/library/papers/11849399PubMed
833235391Mitochondrial quality control in kidney injury and repair.Nat Rev Nephrol2021https://conductscience.org/library/papers/33235391PubMed
936758124Organ Protection by Caloric Restriction Depends on Activation of the De Novo NAD+ Synthesis Pathway.J Am Soc Nephrol2023https://conductscience.org/library/papers/36758124PubMed
1023014458Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury.Kidney Int2013https://conductscience.org/library/papers/23014458PubMed
1132075806Long-Term Outcomes in Patients with Acute Kidney Injury.Clin J Am Soc Nephrol2020https://conductscience.org/library/papers/32075806PubMed
1228947737Gender Differences in the Acute Kidney Injury to Chronic Kidney Disease Transition.Sci Rep2017https://conductscience.org/library/papers/28947737PubMed
1338152989Metabolic Communication by SGLT2 Inhibition.Circulation2024https://conductscience.org/library/papers/38152989PubMed
1433005037Organ protection by SGLT2 inhibitors: role of metabolic energy and water conservation.Nat Rev Nephrol2021https://conductscience.org/library/papers/33005037PubMed
1534901920Genetically encoded biosensors for evaluating NAD+/NADH ratio in cytosolic and mitochondrial compartments.Cell Rep Methods2021https://conductscience.org/library/papers/34901920PubMed
1628255001Physiology and Pathophysiology of the Intrarenal Renin-Angiotensin System: An Update.J Am Soc Nephrol2017https://conductscience.org/library/papers/28255001PubMed
1727391020Dapagliflozin, SGLT2 Inhibitor, Attenuates Renal Ischemia-Reperfusion Injury.PLoS One2016https://conductscience.org/library/papers/27391020PubMed
1830107561Delayed spironolactone administration prevents the transition from acute kidney injury to chronic kidney disease through improving renal inflammation.Nephrol Dial Transplant2019https://conductscience.org/library/papers/30107561PubMed
1935276204Kidney repair and regeneration: perspectives of the NIDDK (Re)Building a Kidney consortium.Kidney Int2022https://conductscience.org/library/papers/35276204PubMed
2026361797Sulfenic Acid Modification of Endothelin B Receptor is Responsible for the Benefit of a Nonsteroidal Mineralocorticoid Receptor Antagonist in Renal Ischemia.J Am Soc Nephrol2016https://conductscience.org/library/papers/26361797PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/38516890/references